Katarzyna Wawrzycka-Adamczyk

Dr. Katarzyna Wawrzycka-Adamczyk

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
KWKatarzyna Wawrzycka-Adamczyk
Katarzyna Wawrzycka-Adamczyk
MKMariusz Korkosz
Mariusz Korkosz
JMJacek Musiał
Jacek Musiał
KWKrzysztof Wójcik
Krzysztof Wójcik
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group of rare diseases with a chronic and relapsing course. Recent treatment guidelines offer many therapeutic options depending mainly on the type of diagnosis and disease manifestations. Areas that remain under discussion include whether all patients diagnosed with AAV belong to a homogeneous group with a similar prognosis at baseline or if the type and duration of remission-inducing treatment should depend on factors other than just diagnosis and disease severity. The aim of this review is to present the recent literature on the tools available to use while evaluating the risk of relapse in patients upon presentation as well as potential biomarkers of proceeding flare in patients upon remission.

1 January 2020 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
MSMarcin Surmiak
Marcin Surmiak
AGAnna Gielicz
Anna Gielicz
DSDarko Stojkov
Darko Stojkov
RSRafał Szatanek
Rafał Szatanek
KWKatarzyna Wawrzycka-Adamczyk
Katarzyna Wawrzycka-Adamczyk
MSMarek Sanak
Marek Sanak
Marcin Surmiak, Anna Gielicz, Darko Stojkov, Rafał Szatanek, Katarzyna Wawrzycka-Adamczyk, Shida Yousefi, Hans-Uwe Simon, Marek Sanak

29 July 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
ADAnna Drynda
Anna Drynda
MSMarcin Surmiak
Marcin Surmiak
Stanislawa Bazan-SochaStanislawa Bazan-Socha
Stanislawa Bazan-Socha
KWKatarzyna Wawrzycka-Adamczyk
Katarzyna Wawrzycka-Adamczyk
MKMariusz Korkosz
Mariusz Korkosz
KWKrzysztof Wójcik
Krzysztof Wójcik
Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) is a heterogeneous group of small-vessel vasculitides, characterized by the presence of antibodies binding to myeloperoxidase (MPO) and proteinase-3 (PR3) found in neutrophil granules. Apart from being the target of ANCA, neutrophils actively contribute to the vicious cycle of inflammation and vascular damage in AAV. On the other hand, platelets have recently been recognized as essential for thrombosis and as inflammatory effectors that collaborate with neutrophils, reinforcing the generation of reactive oxygen species (ROS) and the formation of neutrophil extracellular traps (NETs) in those diseases. Neutrophils exhibit morphological and functional heterogeneity in AAV, reflecting the complexity of their contribution to disease pathogenesis. Since long-term immunosuppression may be related to serious infections and malignancies, there is an urgent need for reliable biomarkers of disease activity to optimize the management of AAV. This review summarizes the current understanding of the role of neutrophils and platelets in the pathogenesis of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), focusing on their crosstalk, and highlights the potential for identifying novel biomarkers relevant for predicting the disease course and its relapses.

28 January 2022 in Polish Archives of Internal Medicine
Verified
Journal Article
Closed access
KWKatarzyna Wawrzycka-Adamczyk
Katarzyna Wawrzycka-Adamczyk
AMAleksandra Matyja-Bednarczyk
Aleksandra Matyja-Bednarczyk
AGAgnieszka Giza
Agnieszka Giza
ŁCŁukasz Chmura
Łukasz Chmura
JKJoanna Kosałka-Węgiel
Joanna Kosałka-Węgiel
SBStanisława Baza-Socha
Stanisława Baza-Socha
DOI: 10.20452/pamw.16202, Published online: January 28, 2022, Authors: Katarzyna Wawrzycka-Adamczyk, Aleksandra Matyja-Bednarczyk, Agnieszka Giza, Łukasz Chmura, Joanna Kosałka-Węgiel, Stanisława Baza-Socha

7 November 2026 in Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
Radosław DziedzicRadosław Dziedzic
Radosław Dziedzic
OLOlga Lipczyńska
Olga Lipczyńska
ADAnna Drynda
Anna Drynda
TITeresa Iwaniec
Teresa Iwaniec
KWKatarzyna Wawrzycka-Adamczyk
Katarzyna Wawrzycka-Adamczyk
KWKrzysztof Wójcik
Krzysztof Wójcik
Antineutrophil cytoplasmic antibody(ANCA)-associated vasculitis (AAV) is a rare, systemic autoimmune disease that can lead to thrombosis and vascular damage. Previous studies demonstrated prothrombotic changes in peripheral blood in AAV patients. We evaluated activity and levels of coagulation contact system factors, including factor(F)XI, FXII, and C1 inhibitor (C1inh), in patients with AAV compared with healthy controls. In this case-control study, 42 patients diagnosed with AAV and 42 age- and sex-matched healthy controls were enrolled. At baseline, most patients were in remission or had low disease activity (median BVAS: 0, Q1-Q3: 0–2). The activities of FXI and FXII were measured by coagulometric methods (FXI: C and FXII: C), and the antigen levels of FXI and FXII were evaluated using an immunoenzymatic method (FXI: Ag and FXII: Ag). The activity of C1inh was assessed by the chromogenic method (C1inh: Ac). Thrombin generation was assessed using the Calibrated Automated Thrombogram (CAT) assay, including thrombin peak, endogenous thrombin potential, lag time, and time to peak. The diagnosis of AAV was based on the ACR/EULAR 2022 classification criteria. Patients with AAV had 16.43% higher FXI activity (FXI: C) as compared to controls (median: 128.65% vs. 110.50%, p < 0.001). No differences were observed for FXI: Ag, FXII: C and FXII: Ag between the analyzed groups. Notably, C1inh: Ac was 16.43% higher in AAV patients than in controls (median: 129.00% vs. 110.80%, p < 0.001). Among the AAV group, the age of patients showed a significant positive correlation with FXI: C (R S = 0.37, p = 0.015), FXI: C was positively correlated with FXII: C (R S = 0.33, p = 0.035), and FXI: C also showed a positive correlation with C1inh: Ac (R S = 0.47, p = 0.002). Next, patients with AAV also showed altered thrombin generation dynamics, with higher ETP ( p = 0.017), longer lag time ( p < 0.001), and longer time to thrombin peak ( p = 0.021), while thrombin peak remained comparable to controls ( p = 0.32). During a median follow-up of 3 years, thromboembolic complications occurred in 10 patients (23.8%), including 7 patients with venous and 6 with arterial events, with 3 patients experiencing both types. Patients who developed thromboembolic complications had lower baseline FXI antigen concentrations (by 52.66%, p = 0.02) and lower peak thrombin generation (by 19.21%, p = 0.026). There were no significant differences in the other analyzed coagulometric parameters ( p > 0.05 for all). Our findings indicate alterations in FXI-related coagulation parameters and C1 inhibitor activity in patients with predominantly inactive or low-activity AAV. These observations suggest that abnormalities in hemostatic regulation may persist despite clinical disease control, although their underlying mechanisms and clinical significance require further investigation.

24 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ADAnna Drynda
Anna Drynda
MSMarcin Surmiak
Marcin Surmiak
Stanislawa Bazan-SochaStanislawa Bazan-Socha
Stanislawa Bazan-Socha
KWKatarzyna Wawrzycka-Adamczyk
Katarzyna Wawrzycka-Adamczyk
MKMariusz Korkosz
Mariusz Korkosz
KWKrzysztof Wójcik
Krzysztof Wójcik
Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) is a heterogeneous group of small-vessel vasculitides characterized by the presence of antibodies binding to myeloperoxidase (MPO) and proteinase-3 (PR3), found in neutrophil granules. Apart from being the target of ANCA, neutrophils actively contribute to the vicious cycle of inflammation and vascular damage in AAV. On the other hand, platelets have recently been recognized as essential for thrombosis and as inflammatory effectors that collaborate with neutrophils, reinforcing the generation of reactive oxygen species (ROS) and the formation of neutrophil extracellular traps (NETs) in those diseases. Neutrophils exhibit morphological and functional heterogeneity in AAV, reflecting the complexity of their contribution to disease pathogenesis. Since long-term immunosuppression may be related to serious infections and malignancies, there is an urgent need for reliable biomarkers of disease activity to optimize the management of AAV. This review summarizes the current understanding of the role of neutrophils and platelets in the pathogenesis of AAV, focusing on their crosstalk, and highlights the potential for identifying novel biomarkers relevant for predicting the disease course and its relapses.